12.07.2015 Views

orlando interview itculture business is business: or is it?

orlando interview itculture business is business: or is it?

orlando interview itculture business is business: or is it?

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ightest students both on the frontline w<strong>it</strong>h patients and in the lab<strong>or</strong>at<strong>or</strong>y developingtreatments and cures. The academic setting, w<strong>it</strong>h the medical school at <strong>it</strong>s c<strong>or</strong>e,allows patients unprecedented access to new developments and technologies at themoment they become available, a key d<strong>is</strong>tinction of univers<strong>it</strong>y-based care.Thanks to the eff<strong>or</strong>ts of prominent Italian physicians, surgeons, and scient<strong>is</strong>tscurrently w<strong>or</strong>king at the Univers<strong>it</strong>y of Miami, UHealth maintains very activepartnerships w<strong>it</strong>h several Italian Univers<strong>it</strong>ies and academic inst<strong>it</strong>utions.In the field of Diabetes research, collab<strong>or</strong>ation w<strong>it</strong>h Italy <strong>is</strong> particularly developed.Dr. Camillo Ric<strong>or</strong>di, Luca Inverardi, Antonello Pileggi, Alberto Pugliese, and LuigiMeneghini of the UM Diabetes Research Inst<strong>it</strong>ute (DRI) w<strong>or</strong>k closely w<strong>it</strong>h theUnivers<strong>it</strong>ies of Milan, Pavia, and P<strong>is</strong>a, along w<strong>it</strong>h the Med<strong>it</strong>erranean Inst<strong>it</strong>ute ofTransplantation and Advanced Therapies (ISMETT) in Palermo, where Dr. Ric<strong>or</strong>dialso serves as President of the Board.H. San Raffaele Inst<strong>it</strong>ute in Milan <strong>is</strong> also home to the DRI-HSR, a Diabetes ResearchInst<strong>it</strong>ute “federated” w<strong>it</strong>h the UM DRI that provides equipment, training, and activecollab<strong>or</strong>ative supp<strong>or</strong>t through a Telescience netw<strong>or</strong>k that involves leading diabetesresearch inst<strong>it</strong>utions w<strong>or</strong>ldwide, collectively f<strong>or</strong>ming the DRI Federation. Finally, theUnivers<strong>it</strong>y of Miami collab<strong>or</strong>ates w<strong>it</strong>h the Facoltá di Scienze Mot<strong>or</strong>ie, whose Dean,Prof. Livio Luzi, <strong>is</strong> also Adjunct Profess<strong>or</strong> at UM-DRI.Partnerships also flour<strong>is</strong>h in numerous other fields of medical research. Dr. PaoloRomanelli and Dr. Joely Kaufman of the UM Department of Dermatology <strong>or</strong>ganizean annual meeting in P<strong>is</strong>a, directed by Dr. Marco Romanelli and th<strong>is</strong> year chairedby Dr. Martin Zaiac, where UM and the Univers<strong>it</strong>y of P<strong>is</strong>a enjoy a long lasting andproductive relationship w<strong>it</strong>h the Department of Dermatology chaired by Prof.Barachini.M<strong>or</strong>eover, at Bascom Palmer Eye Inst<strong>it</strong>ute, ranked number one in the US, Dr. V<strong>it</strong>t<strong>or</strong>ioP<strong>or</strong>ciatti, a graduate of the Univers<strong>it</strong>y of P<strong>is</strong>a, was recently awarded a maj<strong>or</strong> grantfrom the National Inst<strong>it</strong>ute of Health.Add<strong>it</strong>ional UM-Italy partnerships flour<strong>is</strong>h in the area of transplantation and T<strong>is</strong>sueEngineering. At Niguarda Hosp<strong>it</strong>al in Milan, Dr. Ric<strong>or</strong>di’s group <strong>is</strong> w<strong>or</strong>king w<strong>it</strong>h Dr.Mario Marazzi and Dr. Francesca Crovato. At the Univers<strong>it</strong>y of Turin, MolinetteHosp<strong>it</strong>al, active collab<strong>or</strong>ative eff<strong>or</strong>ts are ongoing w<strong>it</strong>h Dr. Luigi Biancone from theDiv<strong>is</strong>ion of Nephrology and the program of cellular transplantation f<strong>or</strong> diabetes.Finally, in the area of biotechnologies, three UM start-up companies, ConvergeBiotech. Inc., LifeGate Inc., and Jotmate Inc. have been establ<strong>is</strong>hed thanks to thecontributions of Italian “Angel Invest<strong>or</strong>s” and “Venture Philanthropy”. A newin<strong>it</strong>iative that involves the commercialization of technologies surrounding a noveltype of adult stem cells (Miami Cells) was spearheaded by UM based Italian scient<strong>is</strong>tDr. Gianluca D’Ippol<strong>it</strong>o. Dr. D’Ippol<strong>it</strong>o <strong>is</strong> now collab<strong>or</strong>ating w<strong>it</strong>h another Italianbasedinvestment group to f<strong>or</strong>m what could become yet another joint commercialin<strong>it</strong>iative between UM and Italian invest<strong>or</strong>s in the area of regenerative medicine.W<strong>it</strong>hout a doubt the ties between Italy and South Fl<strong>or</strong>ida via the Univers<strong>it</strong>y ofMiami and UHealth are strong. As one of the nation’s leading private researchunivers<strong>it</strong>ies, UM takes great pride in <strong>it</strong>s research m<strong>is</strong>sion, and <strong>is</strong> comm<strong>it</strong>ted to theadvancement and commercial application of scientific d<strong>is</strong>coveries. Certainly, Italianscient<strong>is</strong>ts, professionals, and inst<strong>it</strong>utions share a part of that success.<strong>it</strong>aliane stanno fi<strong>or</strong>endo anche in numerosi altri campidella ricerca medica. Il Dott. Paolo Romanelli e il Dott.Joely Kaufman del Dipartimento di Dermatologiadella UM <strong>or</strong>ganizzano un incontro annuale a P<strong>is</strong>a,diretto dal Dott. Marco Romanelli e quest'annopresieduto dal Dott. Martin Zaiac, dove la UM godedi una relazione produttiva e di lunga durata con ilDipartimento di Dermatologia presieduto dal Prof.Barachini dell’Univers<strong>it</strong>á di P<strong>is</strong>a.Inoltre, al Bascom Palmer Eye Inst<strong>it</strong>ute, consideratoil numero uno negli USA, il Dott. V<strong>it</strong>t<strong>or</strong>io P<strong>or</strong>ciatti,laureato all’Univers<strong>it</strong>á di P<strong>is</strong>a, si é recentementeaggiudicato un’imp<strong>or</strong>tante b<strong>or</strong>sa di studio da partedell’Ist<strong>it</strong>uto Nazionale per la Salute (National Inst<strong>it</strong>uteof Health).Altre collab<strong>or</strong>azioni tra UM e l’Italia sono nate nelcampo dei trapianti e dell’ingegneria dei tessutiumani. All’Ospedale Niguarda di Milano, il gruppodel Dott. Ric<strong>or</strong>di sta lav<strong>or</strong>ando con il Dott. MarioMarazzi e la Dott.ssa Francesca Crovato. All’OspedaleMolinette della Univers<strong>it</strong>á di T<strong>or</strong>ino sono in attointensi sf<strong>or</strong>zi di collab<strong>or</strong>azione con il Dott. LuigiBiancone della Div<strong>is</strong>ione di Nefrologia e con ilprogramma per il trapianto di cellule nella cura deldiabete.In ultimo, nell’area delle biotecnologie, sono staterecentemente cost<strong>it</strong>u<strong>it</strong>e tre nuove compagnie dellaUM, Converge Biotech. Inc., LifeGate Inc. e JotmateInc., grazie al contributo di invest<strong>it</strong><strong>or</strong>i in cap<strong>it</strong>ale dir<strong>is</strong>chio e venture con invest<strong>it</strong><strong>or</strong>i di fatto <strong>it</strong>aliani. Unanuova iniziativa che riguarda la commercializzazionedelle tecnologie relative ad un nuovo tipo di cellulastaminale adulta (Miami Cells) é stata capeggiatadallo scienziato <strong>it</strong>aliano Dott. Gianluca D’Ippol<strong>it</strong>ocon base alla UM. Il Dott. D’Ippol<strong>it</strong>o sta attualmentecollab<strong>or</strong>ando con un altro gruppo d’investimento<strong>it</strong>aliano per creare quella che potrebbe diventareun’altra iniziativa commerciale congiunta tra la UM einvest<strong>it</strong><strong>or</strong>i <strong>it</strong>aliani nell’area della medicina rigenerativa.I legami tra l’Italia ed il Sud della Fl<strong>or</strong>ida attraversol’Univers<strong>it</strong>á di Miami e l’UHealth sono senza dubbiof<strong>or</strong>ti. F<strong>or</strong>te del suo ruolo trainante tra le univers<strong>it</strong>áprivate americane impegnate nella ricerca, la UM émolto <strong>or</strong>gogliosa della sua m<strong>is</strong>sione, ed é impegnatanell’avanzamento e nell’applicazione commercialedelle scoperte scientifiche. Certamente, gli scienziati<strong>it</strong>aliani, i profession<strong>is</strong>ti e le <strong>is</strong>t<strong>it</strong>uzioni sono parte diquesto successo..9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!